Sensory neuroimmune signaling opens a new precision medicine window for Stevens–Johnson syndrome and toxic epidermal necrolysis. Novera, [S. l.], v. 1, n. 1, 2026. Disponível em: https://submit.noverapress.com/index.php/Novera/article/view/10. Acesso em: 22 apr. 2026.